SMITHKLINE BEECHAM ORAL KYTRIL APPROVED WITH HIGH-DOSE CISPLATIN INDICATION; APRIL LAUNCH SCHEDULED: COMPANY IS ALREADY CONTACTING FORMULARY COMMITTEES
Executive Summary
SmithKline Beecham's oral Kytril will be available in early April following FDA approval March 16, the company said.